ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Convergence of Targeted Therapies and Immuno-Oncology in Sarcoma

George D. Demetri, MD
Published Online:12:40 PM, Tue August 9, 2016

George D. Demetri, MD, senior vice president for Experimental Therapeutics at the Dana-Farber Cancer Institute, professor of Medicine at Harvard Medical School, and co-director of the Ludwig Center at Harvard, discusses the relevance of sarcoma in the converging worlds of targeted therapies and immuno-oncology.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.